Solasia Pharma KK (9SO) Financial Statements
Solasia Pharma KK Financial Overview
Solasia Pharma KK's market cap is currently $41.74M. The company's EPS TTM is $-3.33; its P/E ratio is -8.11; Solasia Pharma KK is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 429.00M | $ 316.00M | $ 617.00M | $ 1.09B | $ 559.00M |
| Gross Profit | $ 171.00M | $ -10.00M | $ -163.00M | $ 128.00M | $ -121.00M |
| Operating Income | $ -859.00M | $ -991.00M | $ -1.14B | $ -1.73B | $ -2.42B |
| EBITDA | $ -822.00M | $ -796.00M | $ -639.00M | $ -1.20B | $ -1.92B |
| Net Income | $ -876.00M | $ -1.94B | $ -1.11B | $ -2.55B | $ -2.48B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.39B | $ 886.00M | $ 728.00M | $ 803.00M | $ 714.00M |
| Total Assets | $ 2.15B | $ 1.36B | $ 2.55B | $ 3.56B | $ 3.76B |
| Total Debt | $ 159.00M | $ 25.00M | $ 60.00M | $ 37.00M | $ 84.00M |
| Net Debt | $ -1.23B | $ -861.00M | $ -668.00M | $ -766.00M | $ -630.00M |
| Total Liabilities | $ 392.00M | $ 203.00M | $ 673.00M | $ 899.00M | $ 1.17B |
| Stockholders' Equity | $ 1.75B | $ 1.16B | $ 1.88B | $ 2.66B | $ 2.59B |
| Cash Flow | |||||
| Free Cash Flow | $ -847.00M | $ -1.03B | $ -359.00M | $ -2.07B | $ -2.48B |
| Operating Cash Flow | $ -847.00M | $ -1.03B | $ -359.00M | $ -2.07B | $ -2.47B |
| Investing Cash Flow | $ -81.00M | $ 0.00 | $ 2.00M | $ -418.00M | $ -164.00M |
| Financing Cash Flow | $ 1.43B | $ 1.18B | $ 275.00M | $ 2.57B | $ 361.00M |
Currency in JPY